Ionis to present at upcoming investor conferences

Rhea-AI Summary

Ionis Pharmaceuticals (NASDAQ: IONS) has announced its participation in six major healthcare investor conferences throughout November and December 2024. The company's management will engage in fireside chats at events including Guggenheim's Inaugural Healthcare Conference, UBS Global Healthcare Conference, Stifel Healthcare Conference, Jefferies London Healthcare Conference, Citi's Global Healthcare Conference, and Piper Sandler Annual Healthcare Conference. Live webcasts will be available on the Ionis website's Investors & Media section, with replays accessible within 48 hours and archived for a time.

CARLSBAD, Calif., Nov. 7, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:

• Guggenheim's Inaugural Healthcare Conference on Wednesday, November 13, 2024
• UBS Global Healthcare Conference on Wednesday, November 13, 2024
• Stifel 2024 Healthcare Conference on Monday, November 18, 2024
• Jefferies London Healthcare Conference on Wednesday, November 20, 2024
• Citi's 2024 Global Healthcare Conference on Tuesday, December 3, 2024
• Piper Sandler 36^th Annual Healthcare Conference on Wednesday, December 4, 2024

A live webcast of these presentations can be accessed on the Investors & Media section of the Ionis website at https://ir.ionis.com/events-and-presentations/upcoming-events. Replays will be available on the Ionis website within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients.

To learn more about Ionis, visit Ionis.com and follow us on X (Twitter) and LinkedIn.

Ionis Pharmaceuticals Investor Contact: 
D. Wade Walke, Ph.D. – ir@ionis.com – 760-603-2331

Ionis Pharmaceuticals Media Contact:
Hayley Soffer – media@ionis.com – 760-603-4679

View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-302297951.html

SOURCE Ionis Pharmaceuticals, Inc.

FAQ

What investor conferences will Ionis (IONS) attend in November 2024?

In November 2024, Ionis will attend Guggenheim's Inaugural Healthcare Conference (Nov 13), UBS Global Healthcare Conference (Nov 13), Stifel Healthcare Conference (Nov 18), and Jefferies London Healthcare Conference (Nov 20).

How can investors watch Ionis (IONS) conference presentations in 2024?

Investors can watch live webcasts of Ionis presentations through the Investors & Media section of the Ionis website at ir.ionis.com. Replays will be available within 48 hours of each presentation.

Which December 2024 healthcare conferences will Ionis (IONS) participate in?

Ionis will participate in Citi's Global Healthcare Conference on December 3, 2024, and Piper Sandler's 36th Annual Healthcare Conference on December 4, 2024.